Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45Prostatic Neoplasms 41Brain Neoplasms 27Lung Neoplasms 19Glioblastoma 17Glioma 16Neoplasms 13Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 13Head and Neck Neoplasms 10Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Uterine Cervical Neoplasms 7Lymphoma 7Carcinoma, Hepatocellular 7Rectal Neoplasms 6Oligodendroglioma 6Gliosarcoma 6Carcinoma, Squamous Cell 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ependymoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Intraductal, Noninfiltrating 5Sarcoma 4Meningioma 4Colonic Neoplasms 4Breast Neoplasms, Male 4

Interventions

Magnetic Resonance Spectroscopy 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cancer of Lymph Node × Magnetic Resonance Spectroscopy × Clear all
NCT01815333 2020-10-19

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

M.D. Anderson Cancer Center

Phase NA Completed
10 enrolled 5 charts

Cancer of Lymph Node

Data powered by HemOnc (CC BY 4.0) Colophon âš¡